SP-MHCI-0343-2

SARS-CoV-2 Replicase polyprotein 1a 4140-4148, CTDDNALAY

US$169.00

In stock

Description

About SARS-CoV-2 Replicase polyprotein 1a 4140-4148, CTDDNALAY

The SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) Replicase polyprotein 1a 1a Peptide (IEDB: 7121) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Replicase polyprotein 1a Peptide, H-CTDDNALAY-OH (Uniprot: P0C6U8 aa: 4140-4148) from JPT is produced under strict quality control and quality management.

SARS-CoV-2 Replicase polyprotein 1a 4140-4148, CTDDNALAY - Specifications

  • Peptide sequence: H-CTDDNALAY-OH
  • Amount: 1 mg
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Covid-19
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for SARS-CoV-2 Replicase polyprotein 1a 4140-4148, CTDDNALAY

References:
Read References with JPT’s Antigen Peptides
SARS-CoV-2 Replicase polyprotein 1a 4140-4148, CTDDNALAY has been described in:
Characterization of pre-existing and induced SARS-CoV-2-specific CD8<sup>+</sup> T cells., Nat Med, 2021 (PMID: 33184509)
SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals., J Clin Invest, 2021 (PMID: 33427749)
Proteasome-inhibited dendritic cells demonstrate improved presentation of exogenous synthetic and natural HLA-class I peptide epitopes., J Immunol Methods, 2006 (PMID: 16336973)

Documentation

Documentation for SARS-CoV-2 Replicase polyprotein 1a 4140-4148, CTDDNALAY

Properties

Properties of SARS-CoV-2 Replicase polyprotein 1a 4140-4148, CTDDNALAY

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Covid-19
Layout: Freeze-dried in glass vial
Organism: SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Protein Name: Replicase polyprotein 1a
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to SARS-CoV-2 Replicase polyprotein 1a 4140-4148, CTDDNALAY

Information Values
Sequence: H-CTDDNALAY-OH
Specifications: 9mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote